We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YETI:NYSEYETI Holdings, Inc. Analysis

Data as of 2026-09-19 - not real-time

$42.21

Latest Price

8/10Risk

Risk Level: High

Executive Summary

At $42.21, YETI Holdings, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it lost 18.6%. RSI sits at 47.9, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at $39.04 up to resistance at $44.40.
Multiples put this in fair territory at a P/E of 18.5. Sell-side targets cluster 29.2% above the current quote. Revenue is growing at 8.5% on a 9.2% profit margin.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 43.2%, a beta of 1.25 and a maximum drawdown of 30.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 4/10 conviction on the long call.

Top Market Events

What Happened? Shares of outdoor lifestyle products brand NYSE:YETI fell 12.7% in the afternoon session after the...ADVFN1monYETI Raises 2026 Earnings Outlook After Strong Q2 Profit BeatYETI Holdings NYSE:YETI delivered second-quarter...Net Sales Increase 9%Raises Full Year 2026 EPS OutlookReturns $130 Million to Shareholders Through Share...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 44.47
  • MACD momentum is positive
  • 30-day price change of -18.6%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 44.47
  • Analyst targets imply +29.2% versus the current price
  • 30-day volatility of 43.2%

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Analyst targets imply +29.2% versus the current price
  • P/E ratio of 18.5
  • Return on equity of 25.3%

Key Metrics & Analysis

Financial Health

Revenue Growth8.50%
Profit Margin9.24%
P/E Ratio18.5
ROE25.32%
ROA11.32%
Debt/Equity41.52
P/B Ratio5.1
Op. Cash Flow$303.6M
Free Cash Flow$127.4M

Technical Analysis

TrendNeutral
RSI47.9
Support$39.04
Resistance$44.40
MA 20$41.24
MA 50$46.08
MA 200$44.47
MACDBullish
VolumeIncreasing
Fear & Greed Index94.98

Valuation

Fair Value$28.26
Target Price$54.53
Upside/Downside29.20%
GradeFair
TypeGrowth

Risk Assessment

Beta1.25
Volatility43.25%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.